Early-Mid April PACT Study 184th event Data will be released. 2/3 mark of Phase 3 Clinical trial. I'm sure there will be a run up as that time approaches. Good data, improvement over 92nd event data and GenVec will go on the run all LONGS are waiting for. Just count down the weeks. Take advantage of the low share price and relax.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.